Background: Scleroderma (SSc) is an autoimmune connective tissue disease with a female preponderance (female to male ratio of 9.7:1) [1] . Sex hormones are thought to play a role in the susceptibility to autoimmune diseases [2] . Objectives: We report 3 cases of SSc in male-to-female transsexuals diagnosed following their male-to-female transition Methods: Medical records of 3 patients diagnosed with SSc after male-to-female transition were reviewed. Disease features, hormonal therapies and surgical interventions related to gender reassignment were collected. Results: At our tertiary University Hospital clinical service, 3 male-to-female transsexual patients were diagnosed with SSc following their surgery between May 1997 and October 2016. All 3 patients had started their transition before the onset of the disease and had not been diagnosed with any autoimmune disease before either starting the hormonal therapy required for the transition or before undergoing plastic surgery interventions. The first case was diagnosed with anti-RNA pol III +ve diffuse cutaneous SSc at the age of 35 yearsa year after the first surgical intervention for infected silicone buttock implants and approximately 5 years of hormonal therapy with combination of mestranol and norethisterone (Norinyl-1 ® ). She experienced scleroderma renal crisis 2 years after the diagnosis and severe vascular involvement with frequent and severe digital ulcers (DU), Raynaud's phenomenon (RP), gastroesophageal reflux disease (GERD), pulmonary arterial hypertension and telangiectasiae. She required chronic dialysis and was treated with mycophenolate mofetil (MMF), rapamycin, bosentan and proton-pump inhibitors (PPI). She eventually died 8 years after the diagnosis. The second case was diagnosed at the of 49 years, approximately 6 months following her gender reassignmentand 5 years after having started hormonal therapy initially with conjugated estrogen isolated from pregnant mares (Premarin ® ) and later with ethinylestradiol and gestodene (Femodene ® ). She developed ANA -ve, antiCCP antibody and rheumatoid factor positive limited cutaneous SSc/rheumatoid arthritis overlap syndrome and experienced severe DUs, RP, GERD, inflammatory arthritis and pulmonary fibrosis (PF). She was treated with MMF, PPI, calcium-channel blocker (CCB) and low-dose steroid therapy with good response. The third case was diagnosed at the age of 43 years, 2 years after having started triptorelin (Decapeptyl ® ) and oestradiol valerate. She had not undergone any surgical intervention prior to her diagnosis. She developed anti-PM/Scl +ve limited cutaneous SSc/myositis overlap syndrome and experienced RP, GERD and PF. She has only been treated with PPI and CCB prior to her reconstructive surgery.
Conclusions: Although still debated, the role of sex hormones in triggering autoimmunity has been suggested in animal models and human studies [2] . The development of SSc in our case series supports the notion that altered profile of sex hormones may modulate autoimmunity in genetically susceptible individuals with distinct clinical and laboratory characteristics. Background: Renal resistive index (RRI) by Doppler ultrasound, reflects changes in both renal vascular and tubular-interstitial compartments and systemic vascular compliance related to physiological (age) and pathological conditions among which hypertension, diabetes mellitus, hyperuricaemia, dyslipidaemia and chronic kidney disease play a major role [1] . Because of the age-related changes in RRI reported in literature [2, 3] the use of a 0.70 cut-off to detect renal damage, as proposed [4], was questioned: renal injury in younger decades (<60yrs) may occur also for RRI value <0.70 and be underestimated. In systemic sclerosis (SSc), RRI was previously correlated with disease duration, glomerular filtration rate and nailfold-videocapillaroscopy pattern [5] [6] [7] , although tested on small samples and not investigating the possible confounding role of age-related RRI values. Objectives: to describe RRI in a larger scleroderma population and to test both the fixed 0.70 RRI cut-off and age-adjusted cut-offs in reflecting renal and other disease-related organ damage. Methods: SSc patients attending classified according to ACR/EULAR 2013 criteria were enrolled. Data on renal arteries Doppler ultrasound (RRI), autoantibodies status and biochemical tests for renal function/damage, subset and extent of skin fibrosis, instrumental assessment for internal organ involvement were collected and analysed as appropriate with SPSS vers 20.0. Considering that age-adjusted mean values were higher in the SSc population compared to literature values for the general population, we created SSc-specific age-adjusted pathologic cut-offs dividing our SSc population in quartiles and considering RRI values above the 75th percentile as pathologic (Table 1) . Results: 190 SSc patients (age 56.3±15.0 years, disease duration 6±8,20 men) were eligible for the study. In the SSc population significant positive correlations between RRI and age, as well as significant associations between RRI and above mentioned general population comorbidities [1], were confirmed. When considering absolute value of RRI, the 0.70 pathologic cut-off and age-adjusted cut-offs validated in the general population [1], only renal function, systolic PAP, DLCO and late nailfold scleroderma pattern were associated with RRI (Figure 1 ). Pathologic RRI identified according to age cut-offs could not detect early renal damage, but was significantly associated with various fibrotic [interstitial lung disease (p=0.015), tendon friction rubs (p=0.032), skin fibrosis vs no skin involvement (p<0.001), 
